Multi-level Determinants of Starting ART Late: Aim 3

CompletedOBSERVATIONAL
Enrollment

1,214

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Human Immunodeficiency Virus (HIV)Acquired Immune Deficiency Syndrome (AIDS)
Trial Locations (6)

Unknown

Ambo Hospital, Āmbo

Bishoftu Hospital, Bishoftu

Fitche Hospital, Fichē

Goba Hospital, Goba

Nekemte Hospital, Nekemte

Shashamene Hospital, Shashamene

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Columbia University

OTHER

NCT01997359 - Multi-level Determinants of Starting ART Late: Aim 3 | Biotech Hunter | Biotech Hunter